{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,27]],"date-time":"2025-03-27T10:48:20Z","timestamp":1743072500130,"version":"3.40.3"},"publisher-location":"Cham","reference-count":13,"publisher":"Springer International Publishing","isbn-type":[{"type":"print","value":"9783030787097"},{"type":"electronic","value":"9783030787103"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-78710-3_39","type":"book-chapter","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T18:04:00Z","timestamp":1623953040000},"page":"406-415","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["In Silico Mapping of the Omecamtiv Mecarbil Effects from the Sarcomere to the Whole-Heart and Back Again"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0111-0047","authenticated-orcid":false,"given":"Stefano","family":"Longobardi","sequence":"first","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7159-0173","authenticated-orcid":false,"given":"Anna","family":"Sher","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4612-6982","authenticated-orcid":false,"given":"Steven A.","family":"Niederer","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,6,18]]},"reference":[{"key":"39_CR1","doi-asserted-by":"publisher","unstructured":"Bakkehaug, J.P., et al.: Myosin activator Omecamtiv mecarbil increases myocardial oxygen consumption and impairs cardiac efficiency mediated by resting myosin ATPase activity. Circ. Hear. Fail. 8(4), 766\u2013775 (2015). https:\/\/doi.org\/10.1161\/CIRCHEARTFAILURE.114.002152","DOI":"10.1161\/CIRCHEARTFAILURE.114.002152"},{"key":"39_CR2","doi-asserted-by":"publisher","unstructured":"Benjamin, E.J., et al.: Heart disease and stroke statistics - 2018 update: a report from the American Heart Association. Circulation 137(12), E67\u2013E492 (2018). https:\/\/doi.org\/10.1161\/CIR.0000000000000558","DOI":"10.1161\/CIR.0000000000000558"},{"key":"39_CR3","doi-asserted-by":"publisher","unstructured":"Horv\u00e1th, B., et al.: Frequency-dependent effects of Omecamtiv mecarbil on cell shortening of isolated canine ventricular cardiomyocytes. Naunyn. Schmiedebergs. Arch. Pharmacol. 390(12), 1239\u20131246 (2017). https:\/\/doi.org\/10.1007\/s00210-017-1422-z","DOI":"10.1007\/s00210-017-1422-z"},{"key":"39_CR4","doi-asserted-by":"publisher","unstructured":"Kampourakis, T., Zhang, X., Sun, Y.B., Irving, M.: Omecamtiv mercabil and blebbistatin modulate cardiac contractility by perturbing the regulatory state of the myosin filament. J. Physiol. 596(1), 31\u201346 (2018). https:\/\/doi.org\/10.1113\/JP275050","DOI":"10.1113\/JP275050"},{"key":"39_CR5","doi-asserted-by":"publisher","unstructured":"Kieu, T.T., Awinda, P.O., Tanner, B.C.: Omecamtiv Mecarbil slows myosin kinetics in skinned rat myocardium at physiological temperature. Biophys. J. 116(11), 2149\u20132160 (2019). https:\/\/doi.org\/10.1016\/j.bpj.2019.04.020","DOI":"10.1016\/j.bpj.2019.04.020"},{"key":"39_CR6","doi-asserted-by":"publisher","unstructured":"Land, S., Niederer, S.A.: A spatially detailed model of isometric contraction based on competitive binding of troponin i explains cooperative interactions between tropomyosin and crossbridges. PLOS Comput. Biol. 11(8) (2015). https:\/\/doi.org\/10.1371\/journal.pcbi.1004376","DOI":"10.1371\/journal.pcbi.1004376"},{"key":"39_CR7","doi-asserted-by":"publisher","unstructured":"Land, S., et al.: An analysis of deformation-dependent electromechanical coupling in the mouse heart. J. Physiol. 590(18), 4553\u20134569 (2012). https:\/\/doi.org\/10.1113\/jphysiol.2012.231928","DOI":"10.1113\/jphysiol.2012.231928"},{"key":"39_CR8","doi-asserted-by":"publisher","unstructured":"Longobardi, S., et al.: Predicting left ventricular contractile function via Gaussian process emulation in aortic-banded rats. Philos. Trans. A. Math. Phys. Eng. Sci. 378(2173), 20190334 (2020). https:\/\/doi.org\/10.1098\/rsta.2019.0334","DOI":"10.1098\/rsta.2019.0334"},{"key":"39_CR9","doi-asserted-by":"publisher","unstructured":"Malik, F.I., et al.: Cardiac Myosin activation: a potential therapeutic approach for systolic heart failure. Science 331(6023) (2011). https:\/\/doi.org\/10.1126\/science.1200113","DOI":"10.1126\/science.1200113"},{"key":"39_CR10","doi-asserted-by":"publisher","unstructured":"Nagy, L., et al.: The novel cardiac myosin activator Omecamtiv mecarbil increases the calcium sensitivity of force production in isolated cardiomyocytes and skeletal muscle fibres of the rat. Br. J. Pharmacol. 172(18), 4506\u20134518 (2015). https:\/\/doi.org\/10.1111\/bph.13235","DOI":"10.1111\/bph.13235"},{"key":"39_CR11","doi-asserted-by":"publisher","unstructured":"Swenson, A.M., et al.: Omecamtiv mecarbil enhances the duty ratio of human $$\\beta $$-cardiac myosin resulting in increased calcium sensitivity and slowed force development in cardiac muscle. J. Biol. Chem. 292(9), 3768\u20133778 (2017). https:\/\/doi.org\/10.1074\/jbc.M116.748780","DOI":"10.1074\/jbc.M116.748780"},{"issue":"9792","key":"39_CR12","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/S0140-6736(11)61219-1","volume":"378","author":"JR Teerlink","year":"2011","unstructured":"Teerlink, J.R., et al.: Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, Omecamtiv mecarbil: a first-in-man study. Lancet 378(9792), 667\u2013675 (2011). https:\/\/doi.org\/10.1016\/S0140-6736(11)61219-1","journal-title":"Lancet"},{"key":"39_CR13","doi-asserted-by":"publisher","unstructured":"Teerlink, J.R., et al.: Cardiac myosin activation with Omecamtiv mecarbil in systolic heart failure. N. Engl. J. Med. 384(2) (2021). https:\/\/doi.org\/10.1056\/NEJMoa2025797","DOI":"10.1056\/NEJMoa2025797"}],"container-title":["Lecture Notes in Computer Science","Functional Imaging and Modeling of the Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-78710-3_39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T17:26:51Z","timestamp":1710264411000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-78710-3_39"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030787097","9783030787103"],"references-count":13,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-78710-3_39","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"type":"print","value":"0302-9743"},{"type":"electronic","value":"1611-3349"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"18 June 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"FIMH","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Functional Imaging and Modeling of the Heart","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Stanford, CA","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"USA","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2021","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"21 June 2021","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"25 June 2021","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"11","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"fimh2021","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/fimh2021.github.io\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"OCS","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"68","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"65","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"0","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"96% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"2-4","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"3","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"The conference took place virtually due to the COVID-19 pandemic","order":10,"name":"additional_info_on_review_process","label":"Additional Info on Review Process","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}